{"id":243,"date":"2020-05-04T18:47:33","date_gmt":"2020-05-04T17:47:33","guid":{"rendered":"https:\/\/ppra.inserm.dev-mlcom.net\/?page_id=243"},"modified":"2021-08-12T08:35:05","modified_gmt":"2021-08-12T07:35:05","slug":"meta-reseau-professionnel","status":"publish","type":"page","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/","title":{"rendered":"M\u00e9ta-r\u00e9seau professionnel"},"content":{"rendered":"\n<p>Dans un contexte de plus en plus comp\u00e9titif, la cr\u00e9ation d\u2019une infrastructure nationale permettant une meilleure structuration et l\u2019interconnexion des r\u00e9seaux existants de recherche et de surveillance (cliniques, \u00e9pid\u00e9miologiques, de sant\u00e9 publique, v\u00e9t\u00e9rinaires et environnementaux) est essentielle pour coordonner les forces et acc\u00e9l\u00e9rer ainsi les recherches sur l\u2019antibior\u00e9sistance.<\/p>\n\n\n\n<p>Pour augmenter la visibilit\u00e9 de la France dans ce domaine, il est important de d\u00e9velopper et d\u2019\u00e9valuer de nouveaux outils diagnostiques, de nouvelles strat\u00e9gies th\u00e9rapeutiques, et d\u2019interventions. Pour atteindre ces objectifs, l\u2019infrastructure s\u2019appuiera sur :<\/p>\n\n\n\n<ul><li>La cr\u00e9ation d\u2019une base de donn\u00e9es relationnelle r\u00e9pertoriant d\u2019une part, l\u2019ensemble des acteurs et des centres\/services impliqu\u00e9s dans la recherche sur l\u2019antibior\u00e9sistance (services cliniques, laboratoires, etc.) et leurs comp\u00e9tences (mat\u00e9riel, ressources humaines) et, d\u2019autre part, les informations concernant les \u00e9tudes en cours, termin\u00e9es ou en pr\u00e9paration, cela dans le but de faciliter la communication et la transmission des informations, les collaborations entre diff\u00e9rents secteurs, le partage des donn\u00e9es et d\u2019informations, le lancement d\u2019\u00e9tudes pilotes et l\u2019optimisation d\u2019essais cliniques ou d\u2019\u00e9tudes interventionnelles (e.g. pr\u00e9vention et contr\u00f4le des infections, bon usage des antibiotiques).<\/li><li>Une mutualisation des connaissances, des comp\u00e9tences et des moyens en proposant : (i) une aide \u00e0 la conception, coordination et r\u00e9alisation des projets ; (ii), le d\u00e9veloppement d\u2019outils communs : proc\u00e9dures qualit\u00e9, outils de communication.<\/li><li>Le renforcement des comp\u00e9tences des membres du r\u00e9seau par l\u2019organisation de divers \u00e9v\u00e8nements : formations, s\u00e9minaires, conf\u00e9rences.<\/li><\/ul>\n\n\n\n<p>En parall\u00e8le, nous proposons de f\u00e9d\u00e9rer tous les acteurs de la surveillance \u00e9pid\u00e9miologique de l\u2019antibior\u00e9sistance et de l\u2019antibioth\u00e9rapie (et autres donn\u00e9es, notamment cliniques) au sein d\u2019un observatoire national en collaborant avec des agences et des r\u00e9seaux comme <a aria-label=\"undefined (s\u2019ouvre dans un nouvel onglet)\" href=\"https:\/\/www.santepubliquefrance.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">Sant\u00e9 publique France<\/a> et <a aria-label=\"undefined (s\u2019ouvre dans un nouvel onglet)\" href=\"https:\/\/resapath.anses.fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">RESAPATH<\/a>, qui couvrent la surveillance humaine et animale, et en y associant la surveillance environnementale (jusqu\u2019\u00e0 pr\u00e9sent peu ou pas couverte) pour g\u00e9n\u00e9rer des donn\u00e9es \u00e9pid\u00e9miologiques les plus exhaustives possibles en mesurant plus sp\u00e9cifiquement l\u2019impact r\u00e9el et le co\u00fbt de l\u2019antibior\u00e9sistance.<\/p>\n\n\n\n<p>\u00c0 terme, la mise en place de ce r\u00e9seau et de l\u2019observatoire devront aboutir \u00e0 une plateforme incontournable et \u00e0 un point de contact unique et facilitant pour le lancement de nouveaux projets nationaux et internationaux, dans des conditions optimales de qualit\u00e9 et d\u2019efficience.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans un contexte de plus en plus comp\u00e9titif, la cr\u00e9ation d\u2019une infrastructure nationale permettant une meilleure structuration et l\u2019interconnexion des r\u00e9seaux existants de recherche et de surveillance (cliniques, \u00e9pid\u00e9miologiques, de sant\u00e9 publique, v\u00e9t\u00e9rinaires et environnementaux) est essentielle pour coordonner les forces et acc\u00e9l\u00e9rer ainsi les recherches sur l\u2019antibior\u00e9sistance. Pour augmenter la visibilit\u00e9 de la France [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":46,"parent":233,"menu_order":6,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>M\u00e9ta-r\u00e9seau professionnel - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"M\u00e9ta-r\u00e9seau professionnel - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Dans un contexte de plus en plus comp\u00e9titif, la cr\u00e9ation d\u2019une infrastructure nationale permettant une meilleure structuration et l\u2019interconnexion des r\u00e9seaux existants de recherche et de surveillance (cliniques, \u00e9pid\u00e9miologiques, de sant\u00e9 publique, v\u00e9t\u00e9rinaires et environnementaux) est essentielle pour coordonner les forces et acc\u00e9l\u00e9rer ainsi les recherches sur l\u2019antibior\u00e9sistance. Pour augmenter la visibilit\u00e9 de la France [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-12T07:35:05+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/\",\"name\":\"M\u00e9ta-r\u00e9seau professionnel - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-metareseau.svg\",\"datePublished\":\"2020-05-04T17:47:33+00:00\",\"dateModified\":\"2021-08-12T07:35:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-metareseau.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-metareseau.svg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PPR Antibior\u00e9sistance\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"M\u00e9ta-r\u00e9seau professionnel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"M\u00e9ta-r\u00e9seau professionnel - Interface nationale ANTIBIOR\u00c9SISTANCE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/","og_locale":"fr_FR","og_type":"article","og_title":"M\u00e9ta-r\u00e9seau professionnel - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Dans un contexte de plus en plus comp\u00e9titif, la cr\u00e9ation d\u2019une infrastructure nationale permettant une meilleure structuration et l\u2019interconnexion des r\u00e9seaux existants de recherche et de surveillance (cliniques, \u00e9pid\u00e9miologiques, de sant\u00e9 publique, v\u00e9t\u00e9rinaires et environnementaux) est essentielle pour coordonner les forces et acc\u00e9l\u00e9rer ainsi les recherches sur l\u2019antibior\u00e9sistance. Pour augmenter la visibilit\u00e9 de la France [&hellip;]","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_modified_time":"2021-08-12T07:35:05+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/","name":"M\u00e9ta-r\u00e9seau professionnel - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-metareseau.svg","datePublished":"2020-05-04T17:47:33+00:00","dateModified":"2021-08-12T07:35:05+00:00","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-metareseau.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/04\/icon-metareseau.svg"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/meta-reseau-professionnel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"PPR Antibior\u00e9sistance","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/ppr-antibioresistance\/"},{"@type":"ListItem","position":3,"name":"M\u00e9ta-r\u00e9seau professionnel"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}}]}},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/pages\/243"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=243"}],"version-history":[{"count":8,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/pages\/243\/revisions"}],"predecessor-version":[{"id":15089,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/pages\/243\/revisions\/15089"}],"up":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/pages\/233"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/46"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}